[PRESS RELEASE] – TALLAHASSEE, Fla., Sept. 22, 2026 – Trulieve Cannabis Corp., a leading and top-performing medical cannabis company in the U.S., announced that the company has been added to the S&P Total Market Index (TMI), S&P Completion Index (CI) and sector sub-indices S&P TMI Health Care and S&P CI Health Care.
"Trulieve's addition to S&P indices represents another important step forward following Trulieve's listing on the New York Stock Exchange and domestication to the U.S.," Trulieve CEO Kim Rivers said. "Index inclusion raises visibility for Trulieve, ultimately improving liquidity and attracting new institutional investors."
The S&P TMI is one of the broadest equity benchmarks published by S&P Dow Jones Indices, encompassing a wide range of U.S. companies that meet eligibility criteria. The S&P CI includes the S&P TMI minus the S&P 500.
